ENTPD1 and systemic lupus erythematosus: Furthermore, CD39 is a possible biomarker that could help in the identification of SLE disease activity, according to receiver operating characteristic (ROC) curve research.<h4>Conclusion</h4>According to this study, CD4-positive T cells' surface CD39 molecule serves a similar purpose to Tregs', namely immunological suppression.